Skip to contentE
Envoy Medical, Inc.
E
COCHEnvoy Medical, Inc. Q2 2024 · 10-Q
Revenue$68.00K$68.00K+7.9% vs Q2 2023 Net Income-$3.95M-$3.95MN/M vs Q2 2023 EPS Diluted-$0.29-$0.29N/M vs Q2 2023 Operating Income-$4,852,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$4,894,000N/M Margins · derivedOperating margin-7135.3%−24.2 pt vs Q2 2023
Net margin-5804.4%+15365.4 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 12, 2024 · 43 d after period end